04/09/2026
Pakistan’s pharmaceutical industry has opposed proposed changes to the country’s drug pricing mechanism, warning that frequent policy revisions could create uncertainty for manufacturers, affect medicine supplies and discourage investment in the sector.
Read story:
Pakistan’s pharma industry opposes proposed drug pricing changes, warning they could affect medicine supplies, investment and affordability.